Critical Neonatal
Heart Disease
A time-critical emergency — recognising ductal-dependent lesions, initiating PGE₁, and understanding staged surgical palliation
What Is Critical Neonatal Heart Disease?
Critical congenital heart disease (CCHD) refers to structural heart defects that require cardiac surgery or catheter-based intervention within the first year of life — most often within hours to days of birth. These lesions are ductal-dependent: the patent ductus arteriosus (PDA) is the only pathway maintaining either pulmonary or systemic blood flow. When the ductus begins to close after birth (normally within 12–72 hours), these babies deteriorate rapidly.
In ductal-dependent lesions, the ductus arteriosus is not a defect — it is the lifeline. As oxygen rises after birth, the ductus begins to constrict. Without prostaglandin E₁ (PGE₁) to maintain ductal patency, the baby can deteriorate into cardiogenic shock or severe cyanosis within hours. Diagnosis and PGE₁ must come before transfer.
Critical CHD is classified into two broad groups based on which circulation the ductus supports:
Ductal-Dependent Pulmonary Blood Flow
The ductus provides the only (or main) route for blood to reach the lungs. Loss of ductal flow → progressive cyanosis.
- Pulmonary atresia (with or without VSD)
- Critical pulmonary stenosis
- Tricuspid atresia (with restricted PA flow)
- Ebstein anomaly (severe)
Ductal-Dependent Systemic Blood Flow
The ductus provides the only route to the systemic circulation. Loss of ductal flow → cardiovascular collapse.
- Hypoplastic Left Heart Syndrome (HLHS)
- Critical aortic stenosis
- Coarctation of the aorta (severe, neonatal)
- Interrupted aortic arch
Ductal-Dependent Mixing / Both
The ductus supports mixing of oxygenated and deoxygenated blood, or both circulations.
- Transposition of the Great Arteries (TGA)
- Truncus arteriosus
- Total anomalous pulmonary venous connection (obstructed TAPVC)
Anatomy of HLHS — The Most Severe Ductal-Dependent Lesion
Hypoplastic Left Heart Syndrome (HLHS) represents the extreme end of left heart hypoplasia — aortic atresia, mitral atresia or stenosis, a severely underdeveloped left ventricle, and a tiny ascending aorta. The right ventricle must support both pulmonary and systemic circulations via the ductus arteriosus. (Rudolph, Ch. 11)
Normal Heart vs. Hypoplastic Left Heart Syndrome (HLHS)
| ✅ Normal Heart | ⚠️ HLHS — Ductus is the Lifeline |
|---|---|
| RIGHT VENTRICLE (normal size) LEFT VENTRICLE (normal size) PA → Lungs Aorta → Body Ductus CLOSED ✓ Normal separate circulations |
ENLARGED Right Ventricle (supports both) Tiny/Atretic LV Large PA Tiny retrograde Aorta DUCTUS must stay open ⚠️ PGE₁ urgently needed |
In HLHS the left heart is severely underdeveloped. The right ventricle must support both pulmonary and systemic circulation through a patent ductus arteriosus — which must be kept open with PGE₁.
In HLHS, the right ventricle must eject blood for both circulations. Systemic blood flow depends entirely on the ductus arteriosus — blood flows from the pulmonary artery through the ductus into the descending aorta, and then retrograde up the tiny ascending aorta to supply the coronary arteries and brain. The ascending aorta may be as small as 3 mm in diameter.
Three Modes of Neonatal Presentation
Critical CHD manifests in three overlapping patterns, each with distinct physiology and management priorities:
🔵 Cyanosis (“Blue Baby”)
Mechanism: Inadequate pulmonary blood flow OR complete mixing of systemic and venous blood with no parallel circulation.
- SpO₂ persistently <85% on room air
- Fails to improve with oxygen (hyperoxia test negative)
- May look “well” initially despite low sats
- Worsens as ductus closes
Examples: Pulmonary atresia, TGA, Tricuspid atresia, TAPVC (obstructed)
🔴 Cardiovascular Collapse / Shock
Mechanism: Loss of ductal-dependent systemic blood flow. Right ventricle can no longer supply the body.
- Weak/absent femoral pulses
- Cold, mottled, grey peripheries
- Metabolic acidosis (pH <7.2)
- Mistaken for septic shock ⚠️
Examples: HLHS, Critical CoA, Interrupted aortic arch, Critical AS
🟠 Cardiac Failure
Mechanism: Volume or pressure overload causing heart to decompensate. Often presents beyond first week.
- Tachycardia, tachypnoea
- Poor feeding, diaphoresis during feeds
- Hepatomegaly, pulmonary congestion
- Failure to thrive
Examples: Large VSD, Complete AVSD, Truncus arteriosus, TAPVC (unobstructed)
A neonate presenting with shock and lactic acidosis at day 3–7 of life is often misdiagnosed as sepsis. If there is no fever, no clear infection source, and femoral pulses are weak, consider ductal-dependent systemic CHD immediately. Start PGE₁ empirically and perform urgent echocardiography — do not wait for blood culture results.
CCHD Screening — Pulse Oximetry Protocol
Since 2012, universal pulse oximetry screening for CCHD has been recommended in all newborns before hospital discharge. It detects lesions that may be clinically silent but haemodynamically significant.
CCHD Pulse Oximetry Screening Protocol
| 🖐 Pre-Ductal Probe Right hand (palm) |
🦶 Post-Ductal Probe Either foot (sole) |
|---|---|
| Measures right arm SpO₂ (pre-ductal blood) |
Measures lower body SpO₂ (post-ductal blood) |
| ✅ PASS (Negative Screen) | ⚠️ FAIL — Refer to NICU / Cardiology |
|---|---|
| SpO₂ ≥95% in BOTH AND difference <3% between sites |
SpO₂ <90% (immediate referral) OR SpO₂ 90–94% on repeat OR difference ≥3% |
CCHD screening at 24–48 hours using pulse oximetry detects critical heart defects before discharge. Both pre-ductal (right hand) and post-ductal (foot) readings are required.
Administer 100% oxygen for 10–15 minutes via headbox or mask. In cardiac lesions with complete mixing or fixed right-to-left shunts, PaO₂ remains <150 mmHg (often <100 mmHg) despite oxygen. In pulmonary causes, PaO₂ typically rises to >200–300 mmHg. This test helps differentiate respiratory vs. cardiac cyanosis but should not delay PGE₁ if cardiac cause is likely.
Prostaglandin E₁ (PGE₁) — The Life-Saving Drug
If a neonate is suspected to have a ductal-dependent cardiac lesion, start PGE₁ immediately and then arrange echocardiography. The risk of delaying PGE₁ far outweighs the risk of giving it to a baby who may not need it. PGE₁ is the bridge to diagnosis and surgery.
| Aspect | Details |
|---|---|
| Drug Name | Alprostadil (PGE₁ / Prostaglandin E₁) |
| Starting Dose | 0.05–0.1 mcg/kg/min IV infusion; can reduce to 0.01–0.05 mcg/kg/min once ductus opens |
| Goal | Maintain or reopen the ductus arteriosus, improving systemic or pulmonary blood flow |
| Response seen | Improvement in oxygenation (pulmonary-dependent lesions) or pulses/perfusion (systemic-dependent lesions) within 15–30 min |
| Side effects | Apnoea (most critical — have bag-mask ready), fever, flushing, hypotension, seizures at high doses |
| Apnoea risk | ~10–12% — intubation may be needed before transport; bag-mask ventilation must be immediately available |
| Contraindications | Obstructed TAPVC (PGE₁ may worsen pulmonary venous hypertension), Eisenmenger physiology |
| Route | Continuous IV infusion only — preferably via peripheral line; do not give as bolus |
Key Critical Neonatal Lesions at a Glance
| Lesion | Presentation | Ductus Supports | Key Finding | Initial Treatment |
|---|---|---|---|---|
| HLHS | Shock + mild cyanosis | Systemic (retrograde) | Absent/weak pulses, no aortic forward flow, tiny ascending Ao on echo | PGE₁ → Norwood Stage 1 |
| Critical CoA | Shock day 2–7 | Systemic (lower body) | Weak femoral pulses, differential BP arms vs legs, metabolic acidosis | PGE₁ → Surgical repair |
| Interrupted Aortic Arch | Severe shock day 1–3 | Systemic (lower body + often arm) | Complete discontinuity of aortic arch; often associated with DiGeorge/22q11 | PGE₁ → Emergency surgical repair |
| TGA (without VSD) | Severe cyanosis day 1 | Mixing (parallel circulations) | SpO₂ 50–70%, “egg on string” on CXR, parallel great vessels | PGE₁ + Balloon atrial septostomy → ASO |
| Pulmonary Atresia (intact septum) | Progressive cyanosis | Pulmonary blood flow | No forward PA flow, severely right heart dominant, sinusoids may supply RV | PGE₁ → Cath/surgical decompression |
| Critical PS | Cyanosis + RVH | Pulmonary blood flow | Domed pulmonary valve, severe RV hypertrophy, RV pressure >systemic | PGE₁ → Balloon pulmonary valvuloplasty |
| Obstructed TAPVC | Cyanosis + pulmonary oedema | None (PGE₁ HARMFUL) | White-out CXR, small heart, severe respiratory distress, ECMO may be needed | Emergency surgical repair — NO PGE₁ |
| Truncus Arteriosus | Failure + mild cyanosis | None (unrestricted PBF) | Single arterial trunk, VSD, bounding pulses, ↑PBF, DiGeorge association | Surgical repair (Rastelli) |
HLHS — Three-Stage Surgical Palliation
HLHS is not correctable — the left heart cannot be rebuilt. The goal is to reconfigure the circulation so the single right ventricle supports systemic circulation, with pulmonary blood flow becoming passive (non-pulsatile). This is achieved in three stages over the first 3–4 years of life.
Three-Stage Palliation: Norwood → Glenn → Fontan
| STAGE 1: Norwood Newborn (1–2 weeks) |
STAGE 2: Hemi-Fontan/Glenn 4–6 months |
STAGE 3: Fontan 2–4 years |
|---|---|---|
| Build neo-aorta RV → neo-aorta BT shunt or Sano shunt ⚠️ Highest risk stage |
SVC → PA connection (Glenn shunt) Upper body venous return goes directly to lungs Reduces RV workload |
IVC → PA connection All venous return → lungs RV pumps only to body Fontan circulation established |
Single ventricle palliation requires 3 staged operations to separate pulmonary and systemic circulations. The Norwood is the most technically demanding and carries the highest risk.
The period between Stage 1 and Stage 2 (the inter-stage) carries the highest mortality risk (~15–20% of Norwood survivors). Families are trained in home monitoring with pulse oximetry. Warning signs include SpO₂ <75%, poor weight gain, or rapid deterioration. Some centres use dedicated “cardiac neurodevelopmental follow-up” programs during this vulnerable period.
The “7 T’s” of Cyanotic Congenital Heart Disease
A classic mnemonic to remember the common cyanotic CHD lesions. These are structural defects where deoxygenated blood bypasses the lungs and enters the systemic circulation:
Tetralogy of Fallot
Most common cyanotic CHD. VSD + RVOTO + RVH + overriding aorta. Variable cyanosis; “Tet spells” in infancy.
Transposition of Great Arteries (TGA)
Parallel circulations. Severe neonatal cyanosis. “Egg on string” CXR. Emergency balloon septostomy + PGE₁ needed.
Truncus Arteriosus
Single vessel exits heart supplying both circulations. VSD always present. Presents with heart failure + mild cyanosis.
Tricuspid Atresia
No right AV valve. Ductal-dependent PBF in most forms. Requires Fontan palliation ultimately.
Total Anomalous Pulmonary Venous Connection (TAPVC)
All pulmonary veins drain anomalously. Obstructed form = neonatal emergency with white-out CXR.
Taussig-Bing Anomaly
Double-outlet RV with subpulmonary VSD. Haemodynamically resembles TGA. Requires arterial switch.
“Truncated” — HLHS and others
Some mnemonics include HLHS (functional single ventricle), pulmonary atresia, or Ebstein anomaly as the 7th “T”.
Emergency Management Flowchart
Approach to the Critically Ill Neonate with Suspected CHD
| Neonatal Cyanosis or Cardiovascular Collapse Suspect Critical CHD |
| ▼ |
| 🔍 Immediate Assessment: SpO₂ pre+post ductal, HR, BP 4-limb, perfusion, glucose |
| ▼ |
| 🚨 START PGE₁ 0.05–0.1 mcg/kg/min IV Prepare for apnoea — have bag-mask / intubation ready |
| ▼ |
| 📋 Urgent ECHO + CXR + ECG + ABG + Glucose + Blood cultures Transfer to cardiac centre if needed |
Critical neonatal CHD is a time-sensitive emergency. PGE₁ should be started before definitive diagnosis is confirmed whenever duct-dependent circulation is suspected.
Frequently Asked Questions
▾
▾
▾
▾
▾
▾
